30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

BioCardia Inc (BCDA)

Track

Over the last 90 days, BioCardia Inc. has seen a net insider buying activity of $24,156, primarily driven by President and CEO Peter Altman. There were 10 buy transactions and zero sell transactions. This activity occurred against a backdrop of a 32.3% stock price decrease over the same period. The last earnings report missed expectations by 23.53%.
Stock chart
Ticker: BCDA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Altman Peter
President and CEO
1 purchase — total 100,000 USD
Buy 9 Jun 2026
Value US$4,265,440.16 | Price 365.91 | Shares 61,133
Buy 20 May 2026
Value US$3,176,522.39 | Price 128.45 | Shares 49,851
Buy 19 May 2026
Value US$190.00 | Price 0.95 | Shares 200
Buy 18 May 2026
Value US$5,244.00 | Price 0.92 | Shares 5,700
Buy 15 May 2026
Value US$5,202.00 | Price 1.02 | Shares 5,100
Buy 29 Apr 2026
Value US$5,550.00 | Price 1.11 | Shares 5,000
Buy 21 Apr 2026
Value US$492.00 | Price 1.23 | Shares 400
Buy 20 Apr 2026
Value US$738.00 | Price 1.23 | Shares 600
Buy 25 Mar 2026
Value US$366.00 | Price 1.22 | Shares 300
Buy 24 Mar 2026
Value US$744.00 | Price 1.24 | Shares 600
Buy 4 Feb 2026
Value US$5,650.00 | Price 1.13 | Shares 5,000
Buy 21 Jan 2026
Value US$402.00 | Price 1.34 | Shares 300
Buy 20 Jan 2026
Value US$792.00 | Price 1.32 | Shares 600
Buy 17 Dec 2025
Value US$1,170.00 | Price 1.30 | Shares 900
Buy 16 Dec 2025
Value US$274.00 | Price 1.37 | Shares 200
Buy 19 Sep 2025
Value US$360,000.00 | Price 1.25 | Shares 288,000
Buy 19 Sep 2025
Value US$498,000.00 | Price 1.25 | Shares 398,400
Buy 19 Sep 2025
Value US$60,000.00 | Price 1.25 | Shares 48,000
Buy 22 Aug 2025
Value US$1,281.00 | Price 1.83 | Shares 700
Buy 13 Aug 2025
Value US$183.00 | Price 1.83 | Shares 100
Buy 12 Aug 2025
Value US$700.40 | Price 1.75 | Shares 400
Buy 11 Aug 2025
Value US$2,988.60 | Price 1.76 | Shares 1,700
Buy 30 Jun 2025
Value US$149,999.68 | Price 2.08 | Shares 72,289
Buy 30 Jun 2025
Value US$9,999.42 | Price 2.08 | Shares 4,819
Buy 30 Jun 2025
Value US$149,999.68 | Price 2.08 | Shares 72,289
Buy 30 Jun 2025
Value US$49,999.20 | Price 2.08 | Shares 24,096
Buy 30 May 2025
Value US$221.00 | Price 2.21 | Shares 100
Buy 22 May 2025
Value US$1,323.00 | Price 1.89 | Shares 700
Buy 20 May 2025
Value US$3,328.00 | Price 2.08 | Shares 1,600
Buy 16 May 2025
Value US$729.60 | Price 2.43 | Shares 300
Buy 14 May 2025
Value US$298.60 | Price 2.99 | Shares 100
Buy 23 Apr 2025
Value US$24,999.32 | Price 1.91 | Shares 13,123
Buy 23 Apr 2025
Value US$49,998.63 | Price 1.91 | Shares 26,246
Buy 23 Apr 2025
Value US$24,999.32 | Price 1.91 | Shares 13,123
Buy 23 Apr 2025
Value US$24,999.32 | Price 1.91 | Shares 13,123
Buy 23 Apr 2025
Value US$249,998.86 | Price 1.91 | Shares 131,233
Buy 23 Apr 2025
Value US$199,998.33 | Price 1.91 | Shares 104,986
Buy 15 Apr 2025
Value US$214.00 | Price 2.14 | Shares 100
Buy 11 Apr 2025
Value US$609.00 | Price 2.03 | Shares 300
Buy 10 Apr 2025
Value US$597.00 | Price 1.99 | Shares 300
Buy 7 Apr 2025
Value US$980.00 | Price 1.96 | Shares 500
Buy 4 Apr 2025
Value US$1,632.00 | Price 2.04 | Shares 800
Buy 3 Apr 2025
Value US$1,320.00 | Price 2.20 | Shares 600
Buy 3 Apr 2025
Value US$2,688.00 | Price 2.24 | Shares 1,200
Buy 2 Apr 2025
Value US$1,115.00 | Price 2.23 | Shares 500
Buy 5 Mar 2025
Value US$2,450.00 | Price 2.45 | Shares 1,000
Buy 4 Mar 2025
Value US$35,732.80 | Price 2.30 | Shares 15,536
Buy 3 Mar 2025
Value US$52,331.90 | Price 2.30 | Shares 22,753
Buy 3 Mar 2025
Value US$1,055.00 | Price 2.11 | Shares 500
Buy 7 Feb 2025
Value US$1,488.00 | Price 2.48 | Shares 600
Buy 30 Jan 2025
Value US$568.82 | Price 2.38 | Shares 239
Buy 29 Jan 2025
Value US$1,200.00 | Price 2.40 | Shares 500
Buy 23 Dec 2024
Value US$2,060.00 | Price 2.06 | Shares 1,000
Sale 20 Dec 2024
Value US$6,514.00 | Price 2.00 | Shares 3,257
Proposed sale 17 Dec 2024
Value US$6,611.00 | Price 2.03 | Shares 3,257
Buy 5 Dec 2024
Value US$555.00 | Price 2.22 | Shares 250
Buy 15 Nov 2024
Value US$2,524.50 | Price 1.87 | Shares 1,350
Buy 1 Jul 2024
Value US$915.00 | Price 3.05 | Shares 300
Buy 28 Jun 2024
Value US$598.00 | Price 2.99 | Shares 200
Buy 21 Jun 2024
Value US$1,645.00 | Price 3.29 | Shares 500
Buy 14 Jun 2024
Value US$1,760.00 | Price 3.52 | Shares 500
Buy 10 Jun 2024
Value US$3,360.00 | Price 3.36 | Shares 1,000
Buy 19 Apr 2024
Value US$1,012.82 | Price 0.37 | Shares 2,750
Buy 28 Mar 2024
Value US$195.00 | Price 0.39 | Shares 500
Buy 13 Feb 2024
Value US$49,999.95 | Price 0.46 | Shares 108,108
Sale 19 Jan 2024
Value US$55,814.86 | Price 0.43 | Shares 129,802
Buy 26 May 2023
Value US$9,920.00 | Price 1.60 | Shares 6,200
Buy 16 Dec 2022
Value US$999,999.84 | Price 1.68 | Shares 595,238
Buy 11 Nov 2022
Value US$2,604.00 | Price 1.86 | Shares 1,400
Buy 10 Nov 2022
Value US$5,797.00 | Price 1.87 | Shares 3,100
Buy 10 Oct 2022
Value US$4,140.00 | Price 2.07 | Shares 2,000
Buy 23 Sep 2022
Value US$2,618.00 | Price 1.87 | Shares 1,400
Buy 22 Sep 2022
Value US$5,611.00 | Price 1.81 | Shares 3,100
Buy 21 Sep 2022
Value US$5,280.00 | Price 1.92 | Shares 2,750
Buy 10 Jun 2022
Value US$6,570.00 | Price 1.46 | Shares 4,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-09 2026-06-09 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
61,133 +28.3%
365.91
US$4,265,440 		61,133 +28.3% 365.91 US$4,265,440
2026-05-21 2026-05-20 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
49,851 -23.5%
128.45
US$3,176,522 		49,851 -23.5% 128.45 US$3,176,522
2026-05-21 2026-05-19 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
49,366 -22.6%
360.33
US$4,212,763 		49,366 -22.6% 360.33 US$4,212,763
2026-05-18 2026-05-18 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
5,700 +2.0%
0.92
US$5,244 		5,700 +2.0% 0.92 US$5,244
2026-05-15 2026-05-15 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
5,100 +1.8%
1.02
US$5,202 		5,100 +1.8% 1.02 US$5,202
2026-04-29 2026-04-29 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
5,000 +1.8%
1.11
US$5,550 		5,000 +1.8% 1.11 US$5,550
2026-04-22 2026-04-21 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
400 +0.1%
1.23
US$492 		400 +0.1% 1.23 US$492
2026-04-22 2026-04-20 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
600 +0.2%
1.23
US$738 		600 +0.2% 1.23 US$738
2026-03-26 2026-03-25 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
300 +0.1%
1.22
US$366 		300 +0.1% 1.22 US$366
2026-03-26 2026-03-24 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
600 +0.2%
1.24
US$744 		600 +0.2% 1.24 US$744
2026-02-04 2026-02-04 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
5,000 +1.9%
1.13
US$5,650 		5,000 +1.9% 1.13 US$5,650
2026-01-21 2026-01-21 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
300 +0.1%
1.34
US$402 		300 +0.1% 1.34 US$402
2026-01-21 2026-01-20 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
600 +0.2%
1.32
US$792 		600 +0.2% 1.32 US$792
2025-12-17 2025-12-17 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
900 +0.3%
1.30
US$1,170 		900 +0.3% 1.30 US$1,170
2025-12-17 2025-12-16 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
200 +0.1%
1.37
US$274 		200 +0.1% 1.37 US$274
2025-09-23 2025-09-19 B Purchase
3.4
Blank Andrew Scott
Non-Executive Director
288,000 +83.2%
1.25
US$360,000 		288,000 +83.2% 1.25 US$360,000
2025-09-23 2025-09-19 B Purchase
3.4
STERTZER SIMON H
Non-Executive Director
398,400 +206.8%
1.25
US$498,000 		398,400 +206.8% 1.25 US$498,000
2025-09-23 2025-09-19 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
48,000 +28.4%
1.25
US$60,000 		48,000 +28.4% 1.25 US$60,000
2025-08-25 2025-08-22 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
700 +0.4%
1.83
US$1,281 		700 +0.4% 1.83 US$1,281
2025-08-13 2025-08-13 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
100 +0.1%
1.83
US$183 		100 +0.1% 1.83 US$183
2025-08-12 2025-08-12 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
400 +0.2%
1.75
US$700 		400 +0.2% 1.75 US$700
2025-08-11 2025-08-11 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
1,700 +1.0%
1.76
US$2,989 		1,700 +1.0% 1.76 US$2,989
2025-07-02 2025-06-30 B Purchase
3.4
Blank Andrew Scott
Non-Executive Director
72,289 +26.4%
2.08
US$150,000 		72,289 +26.4% 2.08 US$150,000
2025-07-02 2025-06-30 B Purchase
2.7
McClung David

Chief Financial Officer

Officer
4,819 +11.2%
2.08
US$9,999 		4,819 +11.2% 2.08 US$9,999
2025-07-02 2025-06-30 B Purchase
3.4
STERTZER SIMON H
Non-Executive Director
72,289 +60.1%
2.08
US$150,000 		72,289 +60.1% 2.08 US$150,000
2025-07-02 2025-06-30 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
24,096 +17.0%
2.08
US$49,999 		24,096 +17.0% 2.08 US$49,999
2025-05-30 2025-05-30 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
100 +0.1%
2.21
US$221 		100 +0.1% 2.21 US$221
2025-05-22 2025-05-22 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
700 +0.5%
1.89
US$1,323 		700 +0.5% 1.89 US$1,323
2025-05-22 2025-05-20 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
1,600 +1.1%
2.08
US$3,328 		1,600 +1.1% 2.08 US$3,328
2025-05-16 2025-05-16 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
300 +0.2%
2.43
US$730 		300 +0.2% 2.43 US$730
2025-05-16 2025-05-14 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
100 +0.1%
2.99
US$299 		100 +0.1% 2.99 US$299
2025-04-28 2025-04-23 B Purchase
3.0
KRASNO RICHARD M
Non-Executive Director
13,123 +417.3%
1.91
US$24,999 		13,123 +417.3% 1.91 US$24,999
2025-04-25 2025-04-23 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
26,246 +23.3%
1.91
US$49,999 		26,246 +23.3% 1.91 US$49,999
2025-04-25 2025-04-23 B Purchase
2.7
McClung David

Chief Financial Officer

Officer
13,123 +43.7%
1.91
US$24,999 		13,123 +43.7% 1.91 US$24,999
2025-04-25 2025-04-23 B Purchase
2.4
Facteau Bill
Non-Executive Director
13,123 +inf%
1.91
US$24,999 		13,123 +inf% 1.91 US$24,999
2025-04-25 2025-04-23 B Purchase
3.4
Blank Andrew Scott
Non-Executive Director
131,233 +97.4%
1.91
US$249,999 		131,233 +97.4% 1.91 US$249,999
2025-04-25 2025-04-23 B Purchase
3.4
STERTZER SIMON H
Non-Executive Director
104,986 +682.7%
1.91
US$199,998 		104,986 +682.7% 1.91 US$199,998
2025-04-17 2025-04-15 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
100 +0.1%
2.14
US$214 		100 +0.1% 2.14 US$214
2025-04-14 2025-04-11 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
300 +0.3%
2.03
US$609 		300 +0.3% 2.03 US$609
2025-04-14 2025-04-10 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
300 +0.3%
1.99
US$597 		300 +0.3% 1.99 US$597
2025-04-08 2025-04-07 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
500 +0.4%
1.96
US$980 		500 +0.4% 1.96 US$980
2025-04-07 2025-04-04 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
800 +0.7%
2.04
US$1,632 		800 +0.7% 2.04 US$1,632
2025-04-04 2025-04-03 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
600 +0.5%
2.20
US$1,320 		600 +0.5% 2.20 US$1,320
2025-04-03 2025-04-03 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
1,200 +1.1%
2.24
US$2,688 		1,200 +1.1% 2.24 US$2,688
2025-04-04 2025-04-02 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
500 +0.5%
2.23
US$1,115 		500 +0.5% 2.23 US$1,115
2025-03-07 2025-03-05 B Purchase
3.4
STERTZER SIMON H
Non-Executive Director
1,000 +1.8%
2.45
US$2,450 		1,000 +1.8% 2.45 US$2,450
2025-03-05 2025-03-04 B Purchase
3.4
STERTZER SIMON H
Non-Executive Director
15,536 +38.3%
2.30
US$35,733 		15,536 +38.3% 2.30 US$35,733
2025-03-05 2025-03-03 B Purchase
3.4
STERTZER SIMON H
Non-Executive Director
22,753 +127.5%
2.30
US$52,332 		22,753 +127.5% 2.30 US$52,332
2025-03-04 2025-03-03 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
500 +0.5%
2.11
US$1,055 		500 +0.5% 2.11 US$1,055
2025-02-11 2025-02-07 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
600 +0.6%
2.48
US$1,488 		600 +0.6% 2.48 US$1,488
2025-01-30 2025-01-30 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
239 +0.2%
2.38
US$569 		239 +0.2% 2.38 US$569
2025-01-30 2025-01-29 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
500 +0.5%
2.40
US$1,200 		500 +0.5% 2.40 US$1,200
2024-12-26 2024-12-23 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
1,000 +0.9%
2.06
US$2,060 		1,000 +0.9% 2.06 US$2,060
2024-12-26 2024-12-20 S Sale
1.4
GILLIS EDWARD M

Senior Vice President, Devices

Officer
3,257 -26.6%
2.00
US$6,514 		3,257 -26.6% 2.00 US$6,514
2024-12-17 2024-12-17 PrS Proposed sale
1.4
GILLIS EDWARD M

Officer

Officer
3,257
2.03
US$6,611 		3,257 2.03 US$6,611
2024-12-09 2024-12-05 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
250 +0.2%
2.22
US$555 		250 +0.2% 2.22 US$555
2024-11-19 2024-11-15 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
1,350 +1.3%
1.87
US$2,524 		1,350 +1.3% 1.87 US$2,524
2024-07-02 2024-07-01 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
300 +0.8%
3.05
US$915 		300 +0.8% 3.05 US$915
2024-07-02 2024-06-28 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
200 +0.5%
2.99
US$598 		200 +0.5% 2.99 US$598
2024-06-24 2024-06-21 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
500 +1.3%
3.29
US$1,645 		500 +1.3% 3.29 US$1,645
2024-06-17 2024-06-14 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
500 +1.3%
3.52
US$1,760 		500 +1.3% 3.52 US$1,760
2024-06-12 2024-06-10 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
1,000 +2.7%
3.36
US$3,360 		1,000 +2.7% 3.36 US$3,360
2024-04-19 2024-04-19 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
2,750 +0.5%
0.37
US$1,013 		2,750 +0.5% 0.37 US$1,013
2024-03-28 2024-03-28 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
500 +0.1%
0.39
US$195 		500 +0.1% 0.39 US$195
2024-02-15 2024-02-13 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
108,108 +24.2%
0.46
US$50,000 		108,108 +24.2% 0.46 US$50,000
2024-01-22 2024-01-19 S Sale
2.3
FROST PHILLIP MD ET AL
Large shareholder
129,802 -6.4%
0.43
US$55,815 		129,802 -6.4% 0.43 US$55,815
2023-05-30 2023-05-26 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
6,200 +1.3%
1.60
US$9,920 		6,200 +1.3% 1.60 US$9,920
2022-12-20 2022-12-16 B Purchase
2.3
FROST PHILLIP MD ET AL
Large shareholder
595,238 +41.6%
1.68
US$1,000,000 		595,238 +41.6% 1.68 US$1,000,000
2022-11-14 2022-11-11 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
1,400 +0.4%
1.86
US$2,604 		1,400 +0.4% 1.86 US$2,604
2022-11-14 2022-11-10 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
3,100 +0.9%
1.87
US$5,797 		3,100 +0.9% 1.87 US$5,797
2022-10-11 2022-10-10 B Purchase
2.7
McClung David

Chief Financial Officer

Officer
2,000 +2.6%
2.07
US$4,140 		2,000 +2.6% 2.07 US$4,140
2022-09-26 2022-09-23 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
1,400 +0.4%
1.87
US$2,618 		1,400 +0.4% 1.87 US$2,618
2022-09-26 2022-09-22 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
3,100 +1.0%
1.81
US$5,611 		3,100 +1.0% 1.81 US$5,611
2022-09-22 2022-09-21 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
2,750 +0.9%
1.92
US$5,280 		2,750 +0.9% 1.92 US$5,280
2022-06-13 2022-06-10 B Purchase
2.0
Altman Peter

President and CEO

Executive Director
4,500 +1.4%
1.46
US$6,570 		4,500 +1.4% 1.46 US$6,570
Explore more

More insider trading research around BioCardia Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America